✦ LIBER ✦

Bone marrow micrometastases in breast cancer patients

✍ Scribed by Rache Simmons; Syed Hoda; Michael Osborne

Book ID: 117023147
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 197 KB
Volume: 180
Category: Article
ISSN: 0002-9610
DOI: 10.1016/s0002-9610(00)00462-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone marrow micrometastases in breast ca

Bone marrow micrometastases in breast cancer patients

✍ Annamaria Molino; Giuseppe Pelosi; Rocco Micciolo; Monica Turazza; Rolando Norti 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 69 KB

Do Bone Marrow Micrometastases Correlate

Do Bone Marrow Micrometastases Correlate with Sentinel Lymph Node Metastases in Breast Cancer Patients?

✍ Susan M. Trocciola; Syed Hoda; Michael P. Osborne; Paul J. Christos; Heather Lev 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Detection of micrometastases in bone mar

Detection of micrometastases in bone marrow and sentinel lymph nodes of breast cancer patients

✍ Jia Zhao; Xiaoan Liu; Lijun Ling 📂 Article 📅 2007 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 349 KB

Bone marrow micrometastases in 109 breas

Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis

✍ Annamaria Molino; Giuseppe Pelosi; Monica Turazza; Loris Sperotto; Andrea Bonett 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 32 KB

Mitotic activity and bone marrow microme

Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients

✍ Bjørnar Gilje; Oddmund Nordgård; Kjersti Tjensvoll; Emiel A. M. Janssen; Håvard 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 377 KB

Persistence of bone marrow micrometastas

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years

✍ Martin J. Slade; Anjana Singh; Brendan M. Smith; Gopi Tripuraneni; Emma Hall; Cl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB

We have previously developed a quantitative PCR (QPCR) technique for the detection of cytokeratin 19 (CK19) transcripts in blood and bone marrow and compared this to immunocytochemistry (ICC). Together, both have shown promise for monitoring therapeutic efficacy in patients with metastatic breast ca